| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Larimar Therapeutics, Inc. (LRMR) has 6 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. LRMR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 9.54M | $39.01M | - | |
| Dir | 664.8K | $2.72M | - | |
| Dir | 19.0K | $77.7K | - | |
| Dir | 19.0K | $77.7K | - | |
| Dir | 19.0K | $77.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Hamilton Thomas Edward51 | Director | Buy | 100,000 | $5.00 | $500,000.00 | +17.7% | - | - | |
| Feb 27, 2026 | Thomas Frank E | Director | Buy | 5,000 | $5.00 | $25,000.00 | +250.0% | - | - | |
| Jul 31, 2025 | Flynn James E62 | Director, 10% Owner, * Director By Deputization | Buy | 9,375,000 | $3.20 | $30,000,000.00 | +55.1% | +24.6% | - | |
| Feb 16, 2024 | Flynn James E62 | Director, 10% Owner, * Director By Deputization | Buy | 4,290,617 | $8.74 | $37,499,992.58 | +35.1% | -41.9% | -73.9% | |
| Feb 16, 2024 | Hamilton Thomas Edward51 | Director | Buy | 57,208 | $8.74 | $499,997.92 | +11.3% | -41.9% | -73.9% | |
| Feb 14, 2024 | Thomas Frank E | Director | Buy | 2,000 | $11.00 | $22,000.00 | New | -34.1% | -72.7% | |
| Dec 7, 2023 | Shankar Gopi | Chief Development Officer | Buy | 5,000 | $3.73 | $18,661.50 | New | +208.8% | +77.5% | |
| May 17, 2023 | Truitt Joseph | Director | Buy | 2,750 | $3.73 | $10,257.50 | New | +13.3% | +101.4% | |
| May 17, 2023 | Celano Michael72 | Chief Financial Officer | Buy | 5,000 | $3.73 | $18,631.50 | +4.6% | +13.3% | +101.4% | |
| May 17, 2023 | Ben-Maimon Carole | President And CEO | Buy | 5,000 | $3.71 | $18,525.00 | +1.9% | +13.3% | +101.4% |